CAS: 171714-84-4 - (+)-2(S)-(4,6-Dimethoxypyrimidin-2-yloxy)-3-methoxy-3,3-diphenylpropionic acid
Formula:C22H22N2O6
InChI:InChI=1S/C22H22N2O6/c1-27-17-14-18(28-2)24-21(23-17)30-19(20(25)26)22(29-3,15-10-6-4-7-11-15)16-12-8-5-9-13-16/h4-14,19H,1-3H3,(H,25,26)/t19-/m1/s1
InChI key:InChIKey=FEJVSJIALLTFRP-LJQANCHMSA-N
SMILES:O=C(O)C(OC=1N=C(OC)C=C(N1)OC)C(OC)(C=2C=CC=CC2)C=3C=CC=CC3
- Synonyms:
- (2S)-2-[(4,6-dimethoxypyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropanoic acid
- (αS)-α-[(4,6-Dimethoxy-2-pyrimidinyl)oxy]-β-methoxy-β-phenylbenzenepropanoic acid
- Benzenepropanoic acid, α-[(4,6-dimethoxy-2-pyrimidinyl)oxy]-β-methoxy-β-phenyl-, (S)-
- Benzenepropanoic acid, α-[(4,6-dimethoxy-2-pyrimidinyl)oxy]-β-methoxy-β-phenyl-, (αS)-
- Darusentan
- Hmr-4005
- Lu-135252
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Darusentan REF: IN-DA00ACLFCAS: 171714-84-4 | 98% | 47.00 €~326.00 € | Mon 16 Dec 24 | |
Darusentan REF: TM-T5458CAS: 171714-84-4 | 98.72% | 49.00 €~721.00 € | Mon 23 Dec 24 | |
Darusentan REF: 3D-WGA71484CAS: 171714-84-4 | Min. 95% | To inquire | Mon 27 Jan 25 |
Ref: IN-DA00ACLF
1mg | 47.00 € | ||
5mg | 59.00 € | ||
10mg | 69.00 € | ||
25mg | 133.00 € | ||
50mg | 173.00 € | ||
100mg | 326.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Darusentan
CAS:171714-84-4
Darusentan (Lu-135252) is a potent inhibitor of endothelin signaling and function in both large and …
Formula:
C22H22N2O6
Purity:
98.72%
Color and Shape:
Solid
Molecular weight:
410.43
Ref: TM-T5458
1mg | 49.00 € | ||
2mg | 69.00 € | ||
5mg | 102.00 € | ||
10mg | 167.00 € | ||
25mg | 302.00 € | ||
50mg | 498.00 € | ||
100mg | 721.00 € | ||
1mL*10mM (DMSO) | 105.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
Darusentan
Controlled ProductCAS:171714-84-4
Darusentan is a drug that is used to treat chronic heart failure. It is a …
Formula:
C22H22N2O6
Purity:
Min. 95%
Molecular weight:
410.42 g/mol
Ref: 3D-WGA71484
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Monday 27 Jan 2025